You have 9 free searches left this month | to do more

nilotinib

Nilotinib is a drug used to treat Chronic Myeloid Leukemia, Gastrointestinal Stromal Tumors, Leukemia, and other conditions. Nilotinib is being actively studied in 28 studies and prior, has been studied in 58.

Top SponsorsTop SitesTop Investigators
Novartis PharmaceuticalsNovartis Investigative SiteAndrew J. Wagner, MD, PhD
Gruppo Italiano Malattie EMatologiche dell'AdultoComplesso Ospedaliero S. Giovanni AddolorataChul Won Jung
M.D. Anderson Cancer CenterDipartimento Emato-Oncologia A.O."Bianchi-Melacrino-Morelli"David Miklos
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
M
Active, not recruiting
  • Chordoma
  • Nilotinib
  • Radiation therapy
  • Boston, Massachusetts
    Massachusetts General Hospital
2021-10-27
Oct 27, 2021
S
Recruiting
  • Chronic Myeloid Leukemia, Chronic Phase
  • Nilotinib
  • Nilotinib
  • Shenzhen, Guangdong, China
    Shenzhen Second People's Hospital
2022-03-15
Mar 15, 2022
S
Completed
  • Ataxia, Cerebellar
  • Ataxia, Progressive
  • Nilotinib
  • Seoul, Korea, Republic of
    Seoul National University Hospital
2021-09-23
Sep 23, 2021
W
Completed
  • Chronic Myeloid Leukemia
  • Nilotinib
  • New York, New York
    Weill Cornell Medical College
2022-03-24
Mar 24, 2022
A
Recruiting
  • Chronic Myelogenous Leukemia
  • Nilotinib
  • Beirut, Lebanon
    American University of Beirut Medical Center
2022-02-14
Feb 14, 2022
N
Active, not recruiting
  • Gastrointestinal Stromal Tumors
  • nilotinib
  • Nagoya, Aichi, Japan
  • +10 more
2021-05-17
May 17, 2021
N
Not yet recruiting
  • Peritoneal Carcinomatosis
  • +7 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022
A
Active, not recruiting
  • Pigmented Villonodular Synovitis
  • +2 more
  • nilotinib
  • Santa Monica, California
  • +6 more
2022-01-31
Jan 31, 2022
N
Active, not recruiting
  • Gastrointestinal Stromal Tumors
  • Nilotinib
  • HUS, Finland
  • +6 more
2021-04-13
Apr 13, 2021
H
Completed
  • Chronic Phase Chronic Myeloid Leukemia
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
2021-01-04
Jan 4, 2021
N
Terminated
  • CML
  • +2 more
  • nilotinib
  • Las Vegas, Nevada
  • +2 more
2021-04-28
Apr 28, 2021
U
Withdrawn
  • Leukemia, Chronic Myeloid
  • Ann Arbor, Michigan
  • +1 more
2021-02-11
Feb 11, 2021
O
Recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +19 more
  • Nilotinib
  • +4 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
2021-03-19
Mar 19, 2021
E
Active, not recruiting
  • Chronic Myeloid Leukemia
  • TKI discontinuation
  • nilotinib
  • Freiburg, Baden-Württemberg, Germany
  • +14 more
2021-11-04
Nov 4, 2021
G
Completed
  • Chronic Graft Versus Host Disease
  • nilotinib
  • Tel Hashomer, Israel
  • +11 more
2021-08-19
Aug 19, 2021
N
No longer available
  • Hypereosinophilic Syndrome (HES)
  • Nilotinib
  • (no location specified)
2021-09-14
Sep 14, 2021
N
Completed
  • Chronic Myelogenous Leukemia
  • Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive)
  • Nilotinib
  • Tokyo, Japan
    Novartis Investigative Site
2020-12-06
Dec 6, 2020
N
Recruiting
  • Chronic Myeloid Leukemia
  • Nilotinib
  • Bari, BA, Italy
  • +28 more
2022-03-30
Mar 30, 2022
N
Available
  • Acute Lymphoblastic Leukemia (ALL)
  • Nilotinib
  • (no location specified)
2021-09-21
Sep 21, 2021
G
Completed
  • Chronic Myeloid Leukemia
  • Nilotinib
  • Ascoli Piceno, Italy
  • +21 more
2022-01-03
Jan 3, 2022